Oral ciprofloxacin vs. intramuscular ceftriaxone as <font color="red">empiric_1</font> <font color="red">treatment_1</font> <font color="red">of_1</font> <font color="red">acute_4</font> <font color="red">invasive_4</font> <font color="red">diarrhea_4</font> <font color="red">in_4</font> <font color="red">children_4</font> <font color="red">._4</font> 
<br>
<br> BACKGROUND <font color="red">Acute_1</font> <font color="red">invasive_1</font> <font color="red">diarrhea_1</font> <font color="red">is_1</font> <font color="red">a_1</font> <font color="red">potentially_1</font> <font color="red">serious_1</font> <font color="red">condition_1</font> <font color="red">in_1</font> <font color="red">children_2</font> <font color="red">._2</font> Because of the increasing resistance of enteric pathogens to commonly used oral antibiotics , intramuscular ceftriaxone has become the routine drug in the treatment of acute invasive diarrhea requiring an emergency visit in southern <font color="red">Israel_1</font> <font color="red">._1</font> The inconvenience of this parenteral regimen created an increased need for oral pediatric formulations for the treatment of invasive diarrhea . 
<br> OBJECTIVES To evaluate the efficacy and safety of a suspension formulation of ciprofloxacin <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">treatment_1</font> <font color="red">of_1</font> <font color="red">acute_3</font> <font color="red">invasive_3</font> <font color="red">diarrhea_3</font> <font color="red">in_3</font> <font color="red">infants_3</font> <font color="red">and_3</font> <font color="red">children_3</font> <font color="red">._3</font> 
<br> PATIENTS AND METHODS <font color="red">From_2</font> <font color="red">July_3</font> <font color="red">1996_3</font> <font color="red">through_3</font> <font color="red">December_3</font> <font color="red">1997_3</font> <font color="red">,_3</font> <font color="red">201_5</font> <font color="red">evaluable_6</font> <font color="red">children_7</font> <font color="red">ages_7</font> <font color="red">6_7</font> <font color="red">months_7</font> <font color="red">to_7</font> <font color="red">10_7</font> <font color="red">years_7</font> <font color="red">(_7</font> <font color="red">35%_7</font> <font color="red"><_7</font> <font color="red">1_7</font> <font color="red">year_7</font> <font color="red">;_7</font> <font color="red">70%_7</font> <font color="red"><3_7</font> <font color="red">years_7</font> <font color="red">)_7</font> <font color="red">presenting_7</font> <font color="red">with_7</font> <font color="red">acute_7</font> <font color="red">invasive_7</font> <font color="red">diarrhea_7</font> <font color="red">at_6</font> <font color="red">the_6</font> <font color="red">Pediatric_6</font> <font color="red">Emergency_6</font> <font color="red">Room_6</font> <font color="red">were_1</font> <font color="red">randomized_1</font> <font color="red">to_1</font> <font color="red">receive_1</font> <font color="red">either_1</font> <font color="red">ciprofloxacin_1</font> <font color="red">suspension_1</font> <font color="red">(_1</font> <font color="red">10_1</font> <font color="red">mg_1</font> <font color="red">/_1</font> <font color="red">kg_1</font> <font color="red">twice_1</font> <font color="red">a_1</font> <font color="red">day_1</font> <font color="red">+_1</font> <font color="red">i_1</font> <font color="red">m_1</font> <font color="red">placebo_1</font> <font color="red">;_1</font> <font color="red">n_1</font> <font color="red">=_1</font> <font color="red">95_1</font> <font color="red">)_1</font> <font color="red">or_1</font> <font color="red">i_1</font> <font color="red">m_1</font> <font color="red">ceftriaxone_1</font> <font color="red">(_1</font> <font color="red">50_1</font> <font color="red">mg_1</font> <font color="red">/_1</font> <font color="red">kg_1</font> <font color="red">/_1</font> <font color="red">day_1</font> <font color="red">+_1</font> <font color="red">placebo_1</font> <font color="red">suspension_1</font> <font color="red">;_1</font> <font color="red">n_1</font> <font color="red">=_1</font> <font color="red">106_1</font> <font color="red">)_1</font> <font color="red">for_1</font> <font color="red">3_1</font> <font color="red">days_1</font> <font color="red">in_1</font> <font color="red">a_1</font> <font color="red">double_1</font> <font color="red">blind_1</font> <font color="red">manner_1</font> <font color="red">._1</font> Stool cultures for Shigella , Salmonella , Campylobacter spp . and diarrheagenic Escherichia coli were obtained on Days 1 , 3 , 4 to 5 and 21 + /- 5 . Clinical response and safety were assessed on Days 1 , 2 , 3 , 4 to 5 and 21 + /- 5 . 
<br> RESULTS <font color="red">We_1</font> <font color="red">isolated_1</font> <font color="red">127_2</font> <font color="red">pathogens_2</font> <font color="red">from_2</font> <font color="red">121_2</font> <font color="red">(_2</font> <font color="red">60%_2</font> <font color="red">)_2</font> <font color="red">patients_2</font> <font color="red">:_2</font> 73 ( 57% ) Shigella ; 23 ( 18% ) Salmonella ; 18 ( 14% ) E. coli ; and 13 ( 10% ) Campylobacter . Overall bacteriologic eradication on Day 4 to 5 was 99% for Shigella , 77% for Salmonella and 77% for Campylobacter , <font color="red">with_1</font> <font color="red">no_1</font> <font color="red">difference_1</font> <font color="red">between_1</font> <font color="red">the_1</font> <font color="red">2_1</font> <font color="red">groups_1</font> <font color="red">._1</font> <font color="red">Clinical_1</font> <font color="red">cure_1</font> <font color="red">or_1</font> <font color="red">improvement_1</font> <font color="red">was_1</font> <font color="red">observed_1</font> <font color="red">in_1</font> <font color="red">100_1</font> <font color="red">and_1</font> <font color="red">99%_1</font> <font color="red">of_1</font> <font color="red">the_1</font> <font color="red">ciprofloxacin_1</font> <font color="red">and_1</font> <font color="red">ceftriaxone_1</font> <font color="red">groups_1</font> <font color="red">,_1</font> respectively . Serum ciprofloxacin values determined on Day 3 of the treatment <font color="red">were_1</font> <font color="red">higher_1</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">majority_1</font> <font color="red">of_1</font> <font color="red">patients_1</font> than were the MIC50 and MIC90 values for the Shigella and Salmonella spp . isolated . Possible <font color="red">drug_1</font> <font color="red">-_1</font> <font color="red">related_1</font> <font color="red">adverse_1</font> <font color="red">events_1</font> <font color="red">occurred_1</font> <font color="red">in_1</font> <font color="red">13_1</font> <font color="red">patients_1</font> [ ciprofloxacin , 8 ( 8% ) ; ceftriaxone , 5 ( 4.7% ) ] and were mild and transient . Joint examination was normal during and after completion of therapy in all patients . 
<br> CONCLUSION Oral ciprofloxacin was as safe and effective as intramuscular ceftriaxone for the empiric treatment of <font color="red">acute_1</font> <font color="red">invasive_1</font> <font color="red">diarrhea_1</font> <font color="red">in_1</font> <font color="red">ambulatory_3</font> <font color="red">pediatric_3</font> <font color="red">patients_3</font> <font color="red">requiring_2</font> <font color="red">an_2</font> <font color="red">emergency_2</font> <font color="red">room_2</font> <font color="red">visit_2</font> <font color="red">._2</font>